PsychoGenics Inc. Awarded $3 Million SBIR Grant to Employ Its AI-Enabled Platforms to Find Treatments for Rare Disorders
August 28, 2024 08:00 AM Eastern Daylight Time PARAMUS, N.J.–(BUSINESS WIRE)–PsychoGenics, a leader in AI-enabled phenotypic drug discovery, has been awarded a Fast Track Small Business Innovation Research (SBIR) grant by NIMH, worth up to…